Developer of patient identification technology platform intended to accelerate drug development and commercialization for biopharmaceutical companies. The company uses a digital platform to find patients with serious diseases and connect them to clinical trials, disease databases, market research and disease awareness efforts, providing biopharmaceutical companies with a rare and important asset of disease database to develop patient-focused clinical research programs.
Most visits will take between 1.5 and 2 hours. The agenda for a specific visit depends on your group, its interests and objectives as well as on the host company. A visit may include a company or industry specific presentation, a discussion around a specific product or service, partnership opportunities, a demo, a meeting of the premises, etc.